Sulphasalazine-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
Khattak
F H
FH
Morris
I M
IM
Mattingly
P C
PC
D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D008875:Middle Aged; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use
D018501:Antirheumatic Agents; D012460:Sulfasalazine